(E)-5-(2-bromovinyl)-2'-Deoxyuridine in the treatment of experimental herpes simplex keratitis.

IDU (5-iodo-2'-deoxyuridine), BVDU [(E)-5-(2-bromovinyl)-2'-deoxyuridine] and placebo ointments were studied for their effects on experimental herpes simplex (type 1) keratoconjuncitivitis in rabbits. When treatment was begun 65 h after virus inoculation, both BVDU and IDU prevented development of k...

Cijeli opis

Bibliografski detalji

Izdano u:	Antimicrob Agents Chemother
Glavni autori:	Maudgal, P C, De Clercq, E, Descamps, J, Missotten, L, De Somer, P, Busson, R, Vanderhaeghe, H, Verhelst, G, Walker, R T, Jones, A S
Format:	Artigo
Jezik:	Inglês
Izdano:	American Society for Microbiology (ASM) 1980
Teme:	Research Article
Online pristup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC283717/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7352751/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.17.1.8
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!